Pseudoephedrine Hydrochloride Tablet
Product Images NDC 0904-6907

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Pseudoephedrine Hydrochloride (NDC 0904-6907). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1215 100gb Ifc Rm 12981 Major 08 20

1215 100gb Ifc Rm 12981 Major 08 20
This is a drug information sheet that contains details about a medication used to relieve nasal congestion due to the common cold, hay fever or other upper respiratory allergies. It contains an active ingredient, Pseudogphedrine HCI 60 mg, as well as warnings not to use if currently taking certain medications for 2 weeks after stopping the medication. It also includes directions on how to take the medication and how much not to exceed. The sheet warns side effects when taking this medication and cautions against use among certain groups, like pregnant and breastfeeding mothers. The inactive ingredients of the medication are also listed.*
FDA Label Image

1215 50bc

1215 50bc
Unit Dose Pseudoephedrine HCI Tablets are used to temporarily relieve sinus congestion, pressure, and nasal congestion due to the common cold, hay fever, or respiratory allergies. It contains the active ingredient, Pseudoepheine Hydrochloride 60 mg as a nasal decongestant. It is important to consult a doctor before use if you have heart disease, high blood pressure, thyroid disease, diabetes, and trouble urinating. The product should not be used if you are currently taking prescription monoamine axidase inhibitors (MAOI) or for 2 weeks after stopping a WMADI drug. If nervousness, dizziness, sleeplessness, or symptoms do not improve after seven days, stop use and contact a doctor. The product is tamper-evident and must not be used if any blister units are torn or broken. If accidentally overdosed, medical help or contact with Poison Control Center is required. It contains inactive ingredients such as Croscarmellose Sodium, Lactose, Magnesium Stearate, Microcrystalline Cellulose, Silica, and Stearic Acid. Further queries or concerns can be answered by MajorĀ® Pharmaceuticals customer service, on 1-800-616-2471.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.